Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Puretech Lyt 100 Inc.

United States 6 Tide Street Suite 400, 02210-2658, United States

About the sponsor

Clinical research activity is centered on idiopathic pulmonary fibrosis, with attention to progressive lung scarring, breathlessness, and decline in pulmonary function.

  • Interstitial lung disease
  • Pulmonary fibrosis
  • Chronic respiratory impairment

The sponsor’s funded trial portfolio reflects interest in treatment options for patients with fibrotic lung disease in the United States and Europe.

About Specializations

Puretech Lyt 100 Inc. runs clinical trials in conditions such as Idiopathic pulmonary fibrosis, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Idiopathic pulmonary fibrosis

Not yet recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Deupirfenidone
  • Sponsor:Puretech Lyt 100 Inc.

Idiopathic pulmonary fibrosis

Not recruiting
Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Deupirfenidone
  • Sponsor:Puretech Lyt 100 Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.